Detalhe da pesquisa
1.
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S.
N Engl J Med
; 386(9): 847-860, 2022 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139271
2.
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
N Engl J Med
; 384(23): 2187-2201, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33882225
3.
Feasibility of tracking invasive Escherichia coli disease among older adults in a community setting: A prospective observational study.
Eur J Clin Microbiol Infect Dis
; 43(3): 541-550, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38236365
4.
Clinical presentation and antimicrobial resistance of invasive Escherichia coli disease in hospitalized older adults: a prospective multinational observational study.
Infection
; 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38267801
5.
Global Distribution of O Serotypes and Antibiotic Resistance in Extraintestinal Pathogenic Escherichia coli Collected From the Blood of Patients With Bacteremia Across Multiple Surveillance Studies.
Clin Infect Dis
; 76(3): e1236-e1243, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35684979
6.
Distribution of extraintestinal pathogenic Escherichia coli O-serotypes and antibiotic resistance in blood isolates collected from patients in a surveillance study in Japan.
J Infect Chemother
; 28(11): 1445-1451, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35843539
7.
Epidemiology and O-Serotypes of Extraintestinal Pathogenic Escherichia coli Disease in Patients Undergoing Transrectal Ultrasound Prostate Biopsy: A Prospective Multicenter Study.
J Urol
; 205(3): 826-832, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33079609
8.
MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol
; 19(7): 916-929, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29908991
9.
Testing interaction between treatment and high-dimensional covariates in randomized clinical trials.
Biom J
; 59(4): 672-684, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27763683
11.
A predictive enrichment procedure to identify potential responders to a new therapy for randomized, comparative controlled clinical studies.
Biometrics
; 72(3): 877-87, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26689167
12.
Safety, Reactogenicity, Immunogenicity, and Dose Selection of 10-Valent Extraintestinal Pathogenic Escherichia coli Bioconjugate Vaccine (VAC52416) in Adults Aged 60-85 Years in a Randomized, Multicenter, Interventional, First-in-Human, Phase 1/2a Study.
Open Forum Infect Dis
; 10(8): ofad417, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37608916
13.
Harmonizing the collection of solicited adverse events in prophylactic vaccine clinical trials.
Expert Rev Vaccines
; 22(1): 849-859, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37750613
14.
Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola.
NPJ Vaccines
; 7(1): 156, 2022 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36450746
15.
Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo.
BMJ Open
; 12(3): e055596, 2022 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35260458
16.
Characterization of Escherichia coli isolates potentially covered by ExPEC4V and ExPEC10V, that were collected from post-transrectal ultrasound-guided prostate needle biopsy invasive urinary tract and bloodstream infections.
Vaccine
; 38(33): 5100-5104, 2020 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32561123
17.
A Th1/IFNγ Gene Signature Is Prognostic in the Adjuvant Setting of Resectable High-Risk Melanoma but Not in Non-Small Cell Lung Cancer.
Clin Cancer Res
; 26(7): 1725-1735, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31732522
18.
Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate.
NPJ Vaccines
; 5(1): 112, 2020 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33335092
19.
Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trials.
Hum Vaccin
; 5(5): 332-40, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19221517
20.
Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial.
Lancet Infect Dis
; 19(6): 631-640, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31079947